Home > Publications database > Kommentare zu M. Adams & T. Effertz (2020). Zielgenaue Besteuerung des absichtlich erhöhten Suchtpotentials von Zigaretten und neuartigen Nikotinprodukten. > print

001     163846
005     20240229123158.0
024 7 _ |a 10.1024/0939-5911/a000659
|2 doi
024 7 _ |a 0939-5911
|2 ISSN
024 7 _ |a 1617-108X
|2 ISSN
024 7 _ |a 1664-2856
|2 ISSN
037 _ _ |a DKFZ-2020-02086
082 _ _ |a 610
100 1 _ |a Mons, Ute
|0 P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9
|b 0
|e First author
|u dkfz
245 _ _ |a Kommentare zu M. Adams & T. Effertz (2020). Zielgenaue Besteuerung des absichtlich erhöhten Suchtpotentials von Zigaretten und neuartigen Nikotinprodukten.
260 _ _ |a Göttingen
|c 2020
|b Hogrefe
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1601632077_25510
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:M050#LA:M050#
536 _ _ |a 319H - Addenda (POF3-319H)
|0 G:(DE-HGF)POF3-319H
|c POF3-319H
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Hüllinghorst, Rolf
|0 P:(DE-HGF)0
|b 1
|e Last author
773 _ _ |a 10.1024/0939-5911/a000659
|g Vol. 66, no. 3, p. 161 - 163
|0 PERI:(DE-600)2089041-2
|n 3
|p 161 - 163
|t Sucht
|v 66
|y 2020
|x 1664-2856
909 C O |o oai:inrepo02.dkfz.de:163846
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-319H
|2 G:(DE-HGF)POF3-300
|v Addenda
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a Allianz-Lizenz / DFG
|0 StatID:(DE-HGF)0400
|2 StatID
|d 2020-01-16
|w ger
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2020-01-16
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2020-01-16
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-16
920 1 _ |0 I:(DE-He78)M050-20160331
|k M050
|l M050 Krebsprävention
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)M050-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21